Southampton scientists working to improve survival for cancer patients have identified a key characteristic of the disease ...

A research team has revealed a previously unknown mechanism that triggers an inflammatory immune response in cells when their DNA is damaged. This discovery deepens the understanding of a new type of ...

A research team from the University of California, Irvine has revealed a previously unknown mechanism that triggers an inflammatory immune response in cells when their DNA is damaged.

The human immune system is a complex network of cells and signals that guards against disease, yet in the case of cancer, it ...

PITTSBURGH, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced that it has entered into a binding letter of intent with ...

Chicago antibiotic discovery lab engages middle school students from underrepresented communities in hands-on research ...

Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 ...

MOMA-313 is under clinical development by Moma Therapeutics and currently in Phase I for Metastatic Pancreatic Cancer.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

UC San Diego researchers reveal key differences in PD-1 checkpoint receptors between rodents and humans. Rodent PD-1 is ...

New research shows how regular aspirin use can lower cancer risk, especially for those with unhealthy lifestyles. Discover ...

When Sherryl Galang brought her seven-month-old son to the hospital, suspicious of his bloated belly, she had no idea why they admitted him to the oncology ward.